Olanzapine: all 266 studies that test it

Page 3 of 3. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.

• Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With SchizophreniaCompletedNCT00485901Phase 3
• Assessment of a Weight Management Program for Weight Gain in Patients With SchizophreniaCompletedNCT00485823Phase 4
• Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With SchizophreniaCompletedNCT00485810Phase 1/2
• Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I DepressionCompletedNCT00485771Phase 4
• Olanzapine Versus Comparator in the Treatment of Bipolar DisorderCompletedNCT00485680Phase 3
• Managing Acute Schizophrenia, a Comparison Between Two Atypical AntipsychoticsCompletedNCT00485498Phase 4
• Zyprexa and Task Engagement in SchizophreniaWithdrawnNCT00440843Phase 3
• Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological GamblingCompletedNCT00438776Phase 3
• Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSDCompletedNCT00433121Phase 4
• Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac)CompletedNCT00418171Phase 4
• Study Comparing the Affect of Bifeprunox Vs Olanzapine on Weight During the Treatment of Outpatients With Schizophrenia.CompletedNCT00380224Phase 3
• Switch Study of Existing Atypical Antipsychotics to BifeprunoxCompletedNCT00347425Phase 3
• Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or ParkinsonismCompletedNCT00331825Phase 4
• SWitching to Abilify Trial (SWAT)CompletedNCT00304616Phase 4
• Appetite Increase in Schizophrenia Patients Treated With Atypical AntipsychoticsCompletedNCT00290121Phase 4
• Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid MetabolismCompletedNCT00287820Phase 4
• Study of Amantadine for Weight Stabilization During Olanzapine TreatmentCompletedNCT00287352Phase 1
• Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled TrialWithdrawnNCT00273624Phase 3
• Study Evaluating SCA-136 in Subjects With Acute Exacerbations of SchizophreniaCompletedNCT00265551Phase 2
• SB-773812 Administered In Adults With SchizophreniaCompletedNCT00259870Phase 2
• Side Effects of Newer Antipsychotics in Older AdultsCompletedNCT00245206Phase 4
• Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.CompletedNCT00239109Phase 4
• A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT00236379Phase 4
• A Comparison of Two Standard Therapies in the Management of Dementia With AgitationCompletedNCT00208819Phase 4
• Janssen - Glucose Regulation/Risp/OlanzCompletedNCT00205738Not applicable
• Pfizer/IVGTT/Ziprasidone/OlanzapineCompletedNCT00205725Not applicable
• Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic FeaturesCompletedNCT00202293Phase 4
• Pilot Study Evaluating the Safety and Efficacy of Open-Label OlanzapineTerminatedNCT00194064Phase 3
• Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed EpisodeCompletedNCT00191997Phase 4
• A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational ProgrammeCompletedNCT00191828Phase 4
• Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic TreatmentCompletedNCT00191555Phase 4
• Olanzapine Plus Carbamazepine in the Treatment of Bipolar I ManiaCompletedNCT00190892Phase 4
• A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar DisorderCompletedNCT00188942Phase 4
• Determining the Safety and Effectiveness of Olanzapine in Children and AdolescentsTerminatedNCT00183612Not applicable
• Long-Term Olanzapine Treatment in Children With AutismCompletedNCT00183404Phase 2/3
• Olanzapine in the Treatment of Hair Pulling (Trichotillomania)CompletedNCT00182507Phase 4
• Cognition, Functioning and Quality of LifeCompletedNCT00182442Phase 4
• Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II DisorderCompletedNCT00182013Phase 4
• Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar DisorderCompletedNCT00181935Phase 4
• Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant SchizophreniaCompletedNCT00169065Phase 4
• 3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008)CompletedNCT00159744Phase 3
• Energy Homeostasis Under Treatment With Atypical AntipsychoticsCompletedNCT00148564Phase 4
• Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind StudyCompletedNCT00145444Phase 3
• Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced CancerTerminatedNCT00124930Phase 3
• Olanzapine Treated Adolescents With Schizophrenia or Bipolar I DisorderCompletedNCT00113594Phase 3
• The Effects of Risperidone and Olanzapine on ThinkingCompletedNCT00108368Phase 4
• Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With SchizophreniaCompletedNCT00103571Phase 4
• Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective DisorderCompletedNCT00100776Phase 4
• Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I DisorderCompletedNCT00094549Phase 4
• Olanzapine in Patients With Borderline Personality DisorderCompletedNCT00091650Phase 3
• Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective DisorderCompletedNCT00090012Phase 4
• Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in Patients With SchizophreniaCompletedNCT00088491Phase 3
• Study of Olanzapine vs. Aripiprazole in the Treatment of SchizophreniaCompletedNCT00088049Phase 4
• Efficacy and Safety of Olanzapine in Patients With Borderline Personality DisorderCompletedNCT00088036Phase 3
• Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar IllnessTerminatedNCT00071253Phase 4
• A Controlled Study of Olanzapine in Children With AutismCompletedNCT00057408Phase 2
• Olanzapine Versus Placebo in the Treatment of Adolescents With SchizophreniaCompletedNCT00051298Phase 3
• Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I DisorderCompletedNCT00050206Phase 4
• Treating Drug-Resistant Childhood SchizophreniaCompletedNCT00048828Phase 4
• Olanzapine Versus An Active Comparator in the Treatment of SchizophreniaCompletedNCT00036088Phase 4
• The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant DepressionCompletedNCT00035321Phase 3
• CAFE Comparison of Atypicals in First Episode of PsychosisCompletedNCT00034892Phase 3
• Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With SchizophreniaCompletedNCT00034801Phase 4
• Olanzapine Versus Active Comparator in the Treatment of Bipolar I DisorderCompletedNCT00034580Phase 4
• To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of SchizophreniaCompletedNCT00007774Phase 4
• Glucose Regulation During Risperidone and Olanzapine TreatmentStatus unknownNCT00006195Not applicable

← Olanzapine overview